Explore our repository of peer-reviewed studies, white papers, and industry analysis across key sectors.
Nvidia holds 90% of the AI chip market — but Google, Amazon & others are building custom silicon to cut costs, boost performance, and reduce supply chain risk.
Why 45% of GCCs struggle to find the right leaders — and how to build the stakeholder influence, cultural fluency, and strategic storytelling capabilities GCC leaders need.
Evidence-based guide to GCC workforce development in India. Explore the 5-dimension skills spine, 2030 capability roadmap, and talent academies for GCC leaders.
Advanced automation, MES, electronic batch records, and process analytical technology have transformed what pharmaceutical plant and quality roles actually require — yet most manufacturing workforces were qualified for the plant of 2010. This article documents the digital capability gap, defines the four critical 2030 manufacturing and quality competency frontiers, and presents a Manufacturing and Quality 2030 Skills Blueprint.
Conventional learning systems cannot keep pace with the rate of scientific and technological change in biopharma. This article makes the case for repositioning capability development as a board-level strategic asset, describes the four features of a future-fit pharma learning ecosystem, and introduces a Capability-Foresight Cycle for anticipating and building skills ahead of demand.
HCP engagement, patient influence, and commercial value creation are all shifting in ways that existing field force capabilities cannot address. This article maps four new commercial capability dimensions for 2030, presents the Commercial 2030 Capability Model, and examines the learning interventions effectively reskilling today's pharmaceutical commercial teams.
Documentation-centric training is no longer sufficient to satisfy regulators or build real capability. This article contrasts SOP-based and competency-based training architectures, presents the empirical case for simulation, structured OJT, and adaptive learning, and offers a four-stage roadmap for pharmaceutical organisations transitioning from training completed to competence confirmed.
The pharmaceutical industry faces a structural talent gap that headcount alone cannot close. This article examines the rise of the dual-expert archetype — professionals fluent in both scientific and digital domains — maps four critical emerging roles, and presents a 2030 Skills Matrix with a practical framework for redesigning pharma competency models and learning academies.
Green finance is no longer a specialist niche — it is a core banking competency. As climate risk becomes balance-sheet risk and green product demand accelerates, this article outlines how BFSI institutions can build credible green finance capability across risk, product, relationship management, and operations through a structured, phased academy model.
